English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

A number of commercially available devices have been developed to help dermatologists distinguish benign pigmented lesions from malignant melanoma, but it is unclear if and how these technologies should be adopted into clinical practice. This review summarizes the reported diagnostic accuracies of these devices and compares them to clinical exam and dermoscopy. Screening devices appear to have the highest utility in patient populations with a high prevalence of melanoma. However, even in high-risk patients the diagnostic accuracy of evaluative devices is not clearly superior to dermatologists skilled with dermoscopy, potentially limiting their cost effectiveness. General practitioners not skilled with dermoscopy are likely to have larger improvements in diagnostic accuracy when using evaluative devices, however further investigation into the best way to employ them is needed.

Screening and Non-Invasive Evaluative Devices for Melanoma Detection A Comparison of Commercially Available Devices and Dermoscopic Evaluation